1.
Zaurito P, Gedeborg R, Garmo H, Ventimiglia E, Alhberg M, Stattin P, et al. Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study. SJU [Internet]. 2026 Mar. 17 [cited 2026 Jun. 19];61(1):51-7. Available from: https://medicaljournalssweden.se/SJU/article/view/45652